Everstar Therapeutics Limited
1 clinical trials · Sponsor
◉ Watch Everstar Therapeutics Limited
| Record | Firm | Date |
|---|---|---|
| A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis (NCT04176588) | Everstar Therapeutics Limited | 2019-09-10 |
Track Everstar Therapeutics Limited automatically
Every clearance here is in the API, with alerts when new ones post.